Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 8,349 | 5,742 | 28 | 0 | 0 |
| Cost of Goods | 198 | 35 | 1 | N/A | 0 |
| Gross Profit | 8,151 | 5,707 | 27 | N/A | N/A |
| Operating Expenses | 30,216 | 22,924 | 22,090 | 12,633 | 5,155 |
| Operating Income | -21,867 | -17,182 | -22,062 | -12,633 | -5,155 |
| Interest Expense | 2,642 | 6,887 | 0 | 0 | 0 |
| Other Income | 6,529 | 33,349 | -53,609 | -1,101 | -5,743 |
| Pre-tax Income | -17,980 | 9,280 | -75,670 | -13,734 | -10,898 |
| Income Tax | N/A | -2,525 | 65 | N/A | N/A |
| Net Income Continuous | -17,980 | 11,805 | -75,736 | -13,810 | -10,898 |
| Net Income | $-17,980 | $11,805 | $-75,736 | $-13,810 | $-10,898 |
| EPS Basic Total Ops | -0.67 | 0.46 | -3.25 | -0.86 | -0.71 |
| EPS Basic Continuous Ops | -0.67 | 0.46 | -3.25 | -0.86 | -0.71 |
| EPS Diluted Total Ops | -0.84 | -0.77 | -3.25 | -0.86 | -0.71 |
| EPS Diluted Continuous Ops | -0.64 | 0.43 | -3.25 | -0.86 | -0.71 |
| EBITDA(a) | $-19,506 | $-15,556 | $-21,935 | $-12,576 | $-5,101 |